Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 8/20 | 1.00 |
| ▸ | SHBG | P04278 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.78 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cortodoxone SCHEMBL16834876 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL3641463 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL1592553 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL13352414 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL1592718 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL24900239 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL14360590 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL17906542 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| Cortodoxone SCHEMBL13768127 | 1.00 | HSD17B10 (1.00) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 | |
| SCHEMBL6019058 | 0.91 | HSD17B10 (0.84) | HSD17B10SHBGSMN1; SMN2SERPINA6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11710 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260140124-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2026-05-21 | — | — | US | claimed |
| EP-4740024-A1 | ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS | The University Court Of The University of Edinburgh (GB) | 2026-05-13 | — | — | EP | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| EP-4718074-A2 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | Quest Diagnostics Investments Incorporated (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4718073-A2 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | Quest Diagnostics Investments Incorporated (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4687915-A1 | CLASCOTERONE AND MINOXIDIL COMBINATION THERAPY FOR USE IN TREATING HAIR LOSS | Cassiopea S.p.A. (IT) | 2026-02-11 | — | — | EP | claimed |
| US-20250387412-A1 | ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES | CASSIOPEA S.P.A. (IT) | 2025-12-25 | — | — | US | claimed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | claimed |
| EP-0186948-A1 | Process and intermediates for the preparation of 17alpha-hydroxyprogesterones and corticoids from an enol steroid | THE UPJOHN COMPANY (US) | 1986-07-09 | — | — | EP | claimed |
| US-4540564-A | DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1985-09-10 | — | — | US | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4391803-A | STEROID BLEND | HEPAR INDUSTRIES (US) | 1983-07-05 | — | — | US | claimed |
| EP-0005476-B1 | PROCESS FOR PREPARING HUMAN INTERFERON | Dr. Karl Thomae GmbH (DE) | 1981-12-30 | — | — | EP | claimed |
| US-4266024-A | USING ALKYLENEDIAMIDES, DIMETHYL SULFOXIDE OR GLUCOCORTICOIDS AS STIMULATORS FOR LYMPHOID CELLS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-05-05 | — | — | US | claimed |
| US-4220716-A | Process for the preparation of 7α-hydroxylated steroids | HOFFMANN-LA ROCHE INC. (US) | 1980-09-02 | — | — | US | claimed |
| EP-0001102-A1 | Process for the preparation of 7-hydroxy steroids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-03-21 | — | — | EP | claimed |